Recombinant VEGF (Bevacizumab Biosimilar) antibody
Quick Overview for Recombinant VEGF (Bevacizumab Biosimilar) antibody (ABIN7093077)
Target
Antibody Type
Reactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Purpose
- Anti-VEGFA (bevacizumab biosimiar) mAb
-
Characteristics
- MVCD1,VEGF,VPF
-
Purification
- Purified from cell culture supernatant by affinity chromatography
-
Isotype
- IgG1
-
-
-
-
Application Notes
- ELISA 1:5000-10000
-
Comment
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Reconstitute with deionized water
-
Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
-
Expiry Date
- 12 months
-
-
- VEGF (Bevacizumab Biosimilar)
-
Alternative Name
- VEGFA (Bevacizumab Biosimiar)
-
Target Type
- Biosimilar
-
Background
- Synonyms: rhuMAb-VEGF
-
Gene ID
- 7422
-
UniProt
- P15692
Target
-